多发性实性胰腺病变:动态增强CT上非恶性肿瘤的患病率与特征
在三级中心40个月内8096例因疑似胰腺疾病行胰腺动态增强CT检查的患者中,121例检出多发性实性胰腺病变,非恶性肿瘤患病率为19.8%(24/121),最常见为自身免疫性胰腺炎(21例,17.4%)。动态增强CT诊断非恶性肿瘤的敏感度为79.2%、特异度为92.8%;血清IgG4升高、动脉期低强化、平衡期高强化及病变同时位于胰腺近端和远端是非恶性肿瘤的预测因素,而胰管形态和血管侵犯状态则不是。
要点
- 多发性实性胰腺病变中非恶性肿瘤占19.8%(24/121),最常见为自身免疫性胰腺炎(17.4%)。
- 动态增强CT诊断非恶性肿瘤的敏感度79.2%、特异度92.8%。
- 动脉期低强化、平衡期高强化及病变位于胰腺近端和远端提示非恶性肿瘤。
核心结论
- 多发性实性胰腺病变少见且谱系广泛,动态增强CT为识别非恶性肿瘤提供线索。
研究设计与样本
- 回顾性分析三级中心40个月内8096例连续接受胰腺动态增强CT检查的患者,以最终临床/病理诊断为参考标准。
关键影像表现/征象
- 多发性实性胰腺病变中非恶性肿瘤最常见的为自身免疫性胰腺炎(n=21;17.4%)。
- 具有恶性潜能的常见病变包括神经内分泌肿瘤(n=62;51.2%)、导管腺癌(n=15;12.4%)、转移瘤(n=9;7.4%)和淋巴瘤(n=7;5.8%)。
诊断标准与关键数值
- 动态增强CT诊断非恶性肿瘤的敏感度为79.2%、特异度为92.8%。
- 血清IgG4水平升高(p < 0.001)是非恶性肿瘤的预测因素。
- 动脉期低强化(p = 0.001)是非恶性肿瘤的预测因素。
- 平衡期高强化(p = 0.009)是非恶性肿瘤的预测因素。
- 病变同时位于胰腺近端和远端(p = 0.036)是非恶性肿瘤的预测因素。
临床应用与阅片要点
- 对多发性实性胰腺病变,应结合血清IgG4水平及动脉期低强化、平衡期高强化、病变同时位于胰腺近端和远端等CT特征提示非恶性肿瘤可能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine the prevalence of multiple solid pancreatic lesions on dynamic enhanced CT performed for suspected pancreatic diseases, and to identify CT features of non-malignancies.
METHODS: We investigated 8096 consecutive patients who underwent dynamic enhanced CT pancreas protocol at a tertiary center over 40 months. The final clinical /pathological diagnosis served as reference standard. The diagnostic accuracy of dynamic enhanced CT for non-malignancies was calculated. A univariate and multivariate analysis was conducted to identify features that predict non-malignancies.
RESULTS: Multiple solid pancreatic lesions were identified in 121 patients. The prevalence of non-malignancies was 19.8% (24/121). The most common non-malignancy was autoimmune pancreatitis (n = 21; 17.4%). Common lesions with malignant potential included neuroendocrine neoplasia (n = 62; 51.2%), ductal adenocarcinoma (n = 15; 12.4%), metastasis (n = 9; 7.4%), and lymphoma (n = 7; 5.8%). Dynamic enhanced CT had a sensitivity of 79.2% and a specificity of 92.8% for diagnosing non-malignancies. Elevated serum IgG4 level (p < 0.001), hypo-enhancement in arterial phase (p = 0.001), hyper-enhancement in equilibrium phase (p = 0.009) and location in both proximal and distal pancreas (p = 0.036) were predictors of non-malignancies, whereas pancreatic duct morphology and vascular invasion status were not.
CONCLUSION: Multiple solid pancreatic lesions were rare, with a wide spectrum. Dynamic enhanced CT provides clues for identifying non-malignancies.
引用
- Zhu L, Dai MH, Wang ST, et al. Multiple solid pancreatic lesions: Prevalence and features of non-malignancies on dynamic enhanced CT. Eur J Radiol. 2018. PMID: 30017302. doi:10.1016/j.ejrad.2018.05.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。